Can Text Messages Really Improve Endocrine Therapy Adherence?
Oct 01, 2024•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr Anna Singleton is a Senior Research Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Her research focuses on co-designing and implementing accessible, and scalable digital health services to improve health outcomes for people living with and beyond cancer.
We spoke with her about the EMPOWER-SMS clinical trial and what it aims to achieve for breast cancer patients.
For the best experience, listen in Metacast app for iOS or Android